Mepact (mifamurtide) is a small molecule pharmaceutical. Mifamurtide was first approved as Mepact on 2009-03-06. It has been approved in Europe to treat osteosarcoma.
Trade Name |
Mepact |
Common Name |
Mifamurtide |
Indication |
osteosarcoma |
Drug Class |
Peptides: peptides with muranic acid present |